MOR - MorphoSys gains amid takeover speculation
2024-01-26 11:18:29 ET
More on MorphoSys
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis
- MorphoSys: Buying Constellation Was A Desperate Measure
- MorphoSys climbs after late-stage data for blood cancer therapy
- MorphoSys stock tumbles 24% post-market amid Phase 3 data (update)